
Estimates of the cost of taking a drug to market sit comfortably at the $1 billion mark, with much of this vast spend being pumped into lengthy trials and rigorous analytical tests. Proving the efficacy, quality and safety of a pharmaceutical product to gain 100 per cent confidence and approval for market is, clearly, a significant investment.
Let’s take a look at some of the issues and review the latest innovations designed to help manufacturers overcome them...